Cite
HARVARD Citation
Cui, Y. et al. (2018). FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation. Oncogene. 37 (43), pp. 5794-5809. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cui, Y. et al. (2018). FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation. Oncogene. 37 (43), pp. 5794-5809. [Online].